muscle
N |
• normal neuromuscular junctions in quadriceps at age P17
|
• smaller cardiomyocytes
|
• sarcomeric disarray in diaphragm at age P17
|
• decreased myofiber cross-sectional area at age P17
• normal number of nuclei per fiber and percentage Pax7+ satellite cells relative to total number of myonuclei at age P17
• shift towards type I and IIa oxidative fiber composition in quadriceps
• nuclear envelope deformities (jagged appearance, pronounced invaginations and projections that protruded into sarcomeres) in muscle cells, increasing in frequency with age
|
• at age P17
|
• increased fatigue resistance in extensor digitorum longus (EDL) muscle
• increases in fatty acid species and decreases in glycolysis intermediates in hindlimb muscle
|
• reduced tetanic force in extensor digitorum longus (EDL) and soleus muscles at age P17
|
mortality/aging
N |
• mice born at normal Mendelian ratio without obvious anomalies
|
• progressive lethality from age P13; no survival beyond P23
|
cellular
N |
• normal mitochondrial biogenesis in quadriceps muscle
|
• nuclear envelope deformities (jagged appearance, pronounced invaginations and projections that protruded into sarcomeres) in muscle cells, increasing in frequency with age
|
• differential changes in chromatin accessibility in quadriceps muscle: promoters of genes involved in lipid metabolism (e.g. Acyl-CoA transferase 1 (Acot1)) more accessible; genes related to carbohydrate metabolism and muscle contraction (e.g. fast fiber-type myosin-binding protein C (Mybpc2)) less accessible
|
growth/size/body
• failure to thrive; runted appearance by age P7
|
homeostasis/metabolism
N |
• normal circulating insulin levels
|
hypoglycemia
(
J:302139
)
cardiovascular system
N |
• normal heart function
|
• smaller cardiomyocytes
|
behavior/neurological
• waddling gait at P17, associated with increasing number of falls
|
nervous system
N |
• normal neuromuscular junctions in quadriceps at age P17
|